EPH52 Challenges of Missing Specific Disease Codes: Estimating Incidence and Prevalence of Immunoglobulin A Nephropathy (IgAN) Using Health Insurance Claims Data

Value in Health, vol. 27, pp. S232

Authors 8

1. Timotheus Stremel
   Affiliation as printed

   Xcenda GmbH, part of Cencora Inc., Hannover, NI, Germany

2. Matthias Roll

   Vifor Pharma (Germany)

   Affiliation as printed

   CSL Vifor, München, BY, Germany

3. Amadeus Gladbach

   Vifor Pharma (Germany)

   Affiliation as printed

   CSL Vifor, München, BY, Germany

4. Isabella Selinger

   Vifor Pharma (Germany)

   Affiliation as printed

   CSL Vifor, München, BY, Germany

5. Thomas Hardt

   Vifor Pharma (Germany)

   Affiliation as printed

   CSL Vifor, München, BY, Germany

6. Helena Himmelhaus
   Affiliation as printed

   Xcenda GmbH, part of Cencora Inc., Hannover, NI, Germany

7. Julia Theil
   Affiliation as printed

   Xcenda GmbH, part of Cencora Inc., Hannover, NI, Germany

8. Jürgen Floege Aachen

   Universitätsklinikum Aachen

   Affiliation as printed

   Universitätsklinikum Aachen, Aachen, NW, Germany